Cooper J M, Silberzweig J, Mitty H A
Department of Radiology, Mount Sinai Medical Center, New York, NY 10029, USA.
Mt Sinai J Med. 1996 May-Sep;63(3-4):273-81.
Deep venous thrombosis and pulmonary embolus are significant clinical problems. Although anticoagulation remains first-line therapy for thromboembolic disease, the placement of inferior vena cava filters plays an important role as alternative or supplemental therapy. Initial filters were high-profile devices intended to be placed via surgical cutdown. Concerns about the size of the delivery systems prompted development of low-profile systems intended specifically for percutaneous placement. The placement of filters has progressively become a percutaneous procedure performed by interventional radiologists outside of the operating room. This article reviews the currently available devices that have been approved by the Food and Drug Administration, their indications, efficacy, and complications. Experimental temporary filter designs are discussed as well.
深静脉血栓形成和肺栓塞是严重的临床问题。尽管抗凝治疗仍然是血栓栓塞性疾病的一线治疗方法，但下腔静脉滤器的放置作为替代或补充治疗发挥着重要作用。最初的滤器是大型装置，旨在通过外科切开置入。对输送系统尺寸的担忧促使了专门用于经皮置入的小型系统的开发。滤器的放置已逐渐成为介入放射科医生在手术室之外进行的经皮操作。本文回顾了已获美国食品药品监督管理局批准的现有装置、它们的适应证、疗效及并发症。还讨论了实验性临时滤器设计。
